Cellular Logistics and Allele Biotech, a company that explores the mechanisms of biological processes to develop technologies and products for biomedical researchers, have partnered, the company announced recently.

The two companies look to develop regenerative medicine products to treat ischemic heart disease.

According to a release, the relationship was bolstered by the Catalyze Award that Cellular Logistics received, which will accelerate the development studies toward clinical-grade manufacturing of the company’s lead product, SolusTM.

Click here to read the full article.